Bio-Rad Laboratories
$535.079876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$535.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$11.84 (+2.26%) Today
$0.00 (0.00%) As of 5:00 PM EST after-hours
Why Robinhood?
You can buy or sell BIO and other stocks, options, and ETFs commission-free!
About BIO
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA. The listed name for BIO is Bio-Rad Laboratories, Inc.Class A.
CEO
Norman D. Schwartz
Employees
8,120
Headquarters
Hercules, California
Founded
1952
Market Cap
15.96B
Price-Earnings Ratio
4.48
Dividend Yield
—
Average Volume
261.02K
High Today
$536.35
Low Today
$521.92
Open Price
$526.29
Volume
248.18K
52 Week High
$648.39
52 Week Low
$309.38
Collections
BIO Earnings
$0.00
$1.00
$2.00
$3.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 11, After Hours